Lung infections in Influenza-Like Illness (ILI) are triggered by a variety of respiratory viruses.
All human pandemics have been caused by the members of two major virus families …

The recent coronavirus disease 2019 (COVID-19) pandemic was caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is characterized by …

Background The nucleocapsid protein (N protein) is the most abundant protein in SARS-
CoV-2. Viral RNA and this protein are bound by electrostatic forces, forming cytoplasmic …

The genome of severe acute respiratory coronavirus-2 (SARS-CoV-2), the virus responsible
for coronavirus disease 2019 (COVID-19), has undergone a rapid evolution, resulting in the …

SARS-CoV-2 carries a sizeable number of proteins that are accessory to replication but may
be essential for virus–host interactions and modulation of the host immune response. Here …

Coronaviruses constitute a significant threat to the human population. Severe acute
respiratory syndrome coronavirus-2, SARS-CoV-2, is a highly pathogenic human …

SARS-CoV-2 remains a major global public health concern. Antibody waning and immune
escape variant emergence necessitate the development of next generation vaccines that …

Inhalation phage therapy is proposed as a replacement approach for antibiotics in the
treatment of pulmonary bacterial infections. This study investigates phage therapy on …

SARS-CoV-2 is a spherical, positive-sense, single-stranded RNA virus with a large genome,
responsible for encoding both structural proteins, vital for the viral particle's architecture, and …

This manuscript details the application of Isothermal Titration Calorimetry (ITC) to
characterize the kinetics of 3CLpro, the main protease from the Severe Acute Respiratory …